Literature DB >> 6324239

The development of sensitive and specific radioimmunoassays for leukotrienes.

J Rokach, E C Hayes, Y Girard, D L Lombardo, A L Maycock, A S Rosenthal, R N Young, R Zamboni, H J Zweerink.   

Abstract

Radioimmunoassays for leukotriene C4 (LTC4) and for leukotriene B4 (LTB4) have been developed. LTC4 was conjugated with thiolated hemocyanin (Keyhole Limpet) (KLH) using 6-(N-maleimido)hexanoic acid chloride as coupling agent. LTB4 was converted to its hydrazide derivative, via the delta-lactone and the hydrazide was similarly coupled with thiolated KLH using 6-(N-maleimido)hexanoic acid chloride as coupling agent. These conjugates were used to consistently raise high titres of anti-leukotriene antibodies in rabbits. 14,15-[3H]-LTC4 was prepared by total synthesis via two routes. 14,15-[3H]-LTB4 was prepared by total synthesis. The assay for LTC4 recognizes LTC4, LTD4 and LTF4, and to a lesser extent, LTE4 with a detection limit of ca. 0.1 pmoles LTC4 per mL of sample. The assay for LTB4 is highly specific and has a similar detection limit.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324239     DOI: 10.1016/0262-1746(84)90098-2

Source DB:  PubMed          Journal:  Prostaglandins Leukot Med        ISSN: 0262-1746


  13 in total

1.  Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.

Authors:  T R Martin; G Raugi; T L Merritt; W R Henderson
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

2.  Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects.

Authors:  A P Sampson; R U Thomas; J F Costello; P J Piper
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

3.  Identification and characterization of a monocyte-derived neutrophil-activating factor in corticosteroid-resistant bronchial asthma.

Authors:  J R Wilkinson; A E Crea; T J Clark; T H Lee
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

4.  The selective augmentation by recombinant human tumour necrosis factor-alpha of neutrophil responses to pathogenic Escherichia coli.

Authors:  R Steadman; M M Petersen; D Williams; N Matthews; J D Williams
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

5.  Recombinant interferon-gamma primes alveolar macrophages cultured in vitro for the release of leukotriene B4 in response to IgG stimulation.

Authors:  J A Rankin; C E Schrader; S M Smith; R A Lewis
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

6.  Effect of tumor necrosis factor on granule release and LTB4 production in adherent human polymorphonuclear leukocytes.

Authors:  E S Luedke; J L Humes
Journal:  Agents Actions       Date:  1989-06

7.  Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.

Authors:  R C Hubbard; G Fells; J Gadek; S Pacholok; J Humes; R G Crystal
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

8.  Mouse monoclonal antibody to a latent epitope of leucocyte receptors for leukotriene B4.

Authors:  J P Harvey; C H Koo; J M Boggs; R N Young; E J Goetzl
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

9.  Increased leukotriene B4 synthesis in immune injured rat glomeruli.

Authors:  M A Rahman; M Nakazawa; S N Emancipator; M J Dunn
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

10.  Leukotrienes in the sputum and urine of cystic fibrosis children.

Authors:  A P Sampson; D A Spencer; C P Green; P J Piper; J F Price
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.